Patients who stay consistent with follow-ups and track their progress often see better long-term outcomes compared to those who rely on medication alone
A recent cross-sectional study involving 124 participants indicated that 56% of patients still exhibited elevated residual gastric contents despite halting incretin agonists for a minimum of 7 days, thus challenging the practice of discontinuing long-acting GLP-1 RAs solely for this duration prior to surgery [19]
Activation of mTOR leads to inhibition of autophagy [248], generally observed in ASD patients [242, 245, 251, 256]
Even 5-10% weight loss tends to be meaningful
No est aprobada en Mxico, ni por la FDA ni por la EMA
Qualitatively, both self-report and EHR data showed similar distributions for weight loss efficacy (Extended Data Fig